Analysis of belimumab prescription and outcomes in a 10-year monocentric cohort: is there an advantage with early use?
Tani C, Zucchi D, Cardelli C, Elefante E, Signorini V, Schilirò D, Cascarano G, Gualtieri L, Valevich A, Puccetti G, Carli L, Stagnaro C, Mosca M.
Tani C, et al.
RMD Open. 2024 Apr 12;10(2):e003981. doi: 10.1136/rmdopen-2023-003981.
RMD Open. 2024.
PMID: 38609320
Free PMC article.
OBJECTIVE: The objective is to evaluate perscriptions of belimumab (BEL), how these have changed over the years and their impact on clinical outcomes in patients with systemic lupus erythematosus (SLE). ...
OBJECTIVE: The objective is to evaluate perscriptions of belimumab (BEL), how these have changed over the years and their impact on c …